We previously compared changes in individual protein abundance between the proteomes of GS-NSO cell lines with varying rates of cell-specific recombinant monoclonal antibody production (qMab). Here we extend analyses of our proteomic clataset to statistically determine if particular cell lines have distinct functional capabilities that facilitate production of secreted recombinant Mab. We categorized 79 proteins identified by mass spectrometry according to their biological function or location in the cell and statistically compared the relative abundance of proteins in each category between GS-NSO cell lines with varying qMab. We found that the relative abundance of proteins in ER chaperone, non-ER chaperone, cytoskeletal, cell signaling, m...
Despite the recent introduction of next-generation immunotherapeutic agents, multiple myeloma (MM) r...
Chinese hamster ovary (CHO) cells are the preferred production host for therapeutic monoclonal antib...
Here, we provide direct evidence that using recombinant proteins expressed in eukaryotic cells as an...
We previously compared changes in individual protein abundance between the proteomes of GS-NSO cell ...
We have employed an inverse engineering strategy based on quantitative proteome analysis to identify...
The folding, transport and modification of recombinant proteins in the constitutive secretory pathwa...
The folding, transport and modification of recombinant proteins in the constitutive secretory pathwa...
Engineered mammalian (CHO, NS0 and SP2/0) cells are commonly used for large-scale production of reco...
For decades, Chinese hamster ovary (CHO) cells have been the preferred host for therapeutic monoclon...
Most of the recombinant biotherapeutics employed today to combat severe illnesses, for example, vari...
In this study we have analyzed the dynamic covariation of the mammalian cell proteome with respect t...
In this review we consider how cell specific recombinant monoclonal antibody (Mab) production by eng...
The overall goal of this research was to better understand the mechanisms underlying the physiology ...
It has previously been reported that the efficient folding, transport and modifications of recombina...
Chinese hamster ovary (CHO) cells are the preferred production host for therapeutic monoclonal antib...
Despite the recent introduction of next-generation immunotherapeutic agents, multiple myeloma (MM) r...
Chinese hamster ovary (CHO) cells are the preferred production host for therapeutic monoclonal antib...
Here, we provide direct evidence that using recombinant proteins expressed in eukaryotic cells as an...
We previously compared changes in individual protein abundance between the proteomes of GS-NSO cell ...
We have employed an inverse engineering strategy based on quantitative proteome analysis to identify...
The folding, transport and modification of recombinant proteins in the constitutive secretory pathwa...
The folding, transport and modification of recombinant proteins in the constitutive secretory pathwa...
Engineered mammalian (CHO, NS0 and SP2/0) cells are commonly used for large-scale production of reco...
For decades, Chinese hamster ovary (CHO) cells have been the preferred host for therapeutic monoclon...
Most of the recombinant biotherapeutics employed today to combat severe illnesses, for example, vari...
In this study we have analyzed the dynamic covariation of the mammalian cell proteome with respect t...
In this review we consider how cell specific recombinant monoclonal antibody (Mab) production by eng...
The overall goal of this research was to better understand the mechanisms underlying the physiology ...
It has previously been reported that the efficient folding, transport and modifications of recombina...
Chinese hamster ovary (CHO) cells are the preferred production host for therapeutic monoclonal antib...
Despite the recent introduction of next-generation immunotherapeutic agents, multiple myeloma (MM) r...
Chinese hamster ovary (CHO) cells are the preferred production host for therapeutic monoclonal antib...
Here, we provide direct evidence that using recombinant proteins expressed in eukaryotic cells as an...